AMEX : CHRO

Channel Therapeutics Corporation

$1.35 USD

$0.09 (7.14%)

Volume
193.12K
Average Volume
76.4K
Market Capitalization
$8.9M
P/E Ratio
-0.05
Dividend Yield
0.00%
Price Target
Year High
$54.29
Year Low
$1.23
Day High
Day Low
Payout Ratio
$0.00
Current Ratio
$2.79
3333332"{? p/.m7yd f,0=

Annual earnings financials

CHRO financial data with annual/quarterly toggle

CHRO GAAP EPS - Annual & Quarterly

CHRO Sales Revenue - Annual & Quarterly

CHRO Shares Outstanding - Annual & Quarterly

Hover over bars to see exact values. Data includes up to 12 years of annual financials and up to 20 quarters of quarterly data from FMP Financial Data.

CHRO Estimated and Actual Revenue by Quarter
CHRO Estimated and Actual EPS by Quarter
CHRO Analyst Forecasts — EBITDA & EBIT
Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2025-12-31 1 7.51M 7.51M 7.51M 5.63M 5.63M 5.63M
2025-09-30 1 5.92M 5.92M 5.92M 4.44M 4.44M 4.44M
2025-06-30 0 - - - - - -
2025-03-31 0 - - - - - -
2024-12-31 0 - - - - - -
2024-09-30 0 - - - - - -
CHRO Analyst Forecasts — Net Income & SGA Expense
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2025-12-31 1 -4.7M -4.7M -4.7M 20.8M 20.8M 20.8M
2025-09-30 1 -795.99K -795.99K -795.99K 16.41M 16.41M 16.41M
2025-06-30 0 -198.56K -198.56K -198.56K - - -
2025-03-31 0 -1.78M -1.78M -1.78M - - -
2024-12-31 0 -1.19M -1.19M -1.19M - - -
2024-09-30 0 -1.33M -1.33M -1.33M - - -
CHRO Analyst Forecasts — Revenue & EPS
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2025-12-31 1 9.39M 9.39M 9.39M 1 -0.25 -0.25 -0.25
2025-09-30 1 7.41M 7.41M 7.41M 1 -0.26 -0.26 -0.26
2025-06-30 0 - - - 1 -0.31 -0.31 -0.31
2025-03-31 0 - - - 1 -0.29 -0.29 -0.29
2024-12-31 0 - - - 1 -0.21 -0.21 -0.21
2024-09-30 0 - - - 1 -0.23 -0.23 -0.23